Abstract
The in vitro susceptibility of 41 strains of“Campylobacter upsaliensis” to 24 antimicrobial agents was determined using a broth microdilution procedure. Most isolates were susceptible to the fluoroquinolones and β-lactam antibiotics tested, but all strains were resistant to trimethoprim (MBCs ≥ 128 µg/ml) and teicoplanin (MBCs ≥ 32 µg/ml). These agents may be useful in a selective isolation medium for“Campylobacter upsaliensis”.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Goossens H, Pot B, Vlaes L, Van den Borre C, Van den Abbeele R, Van Naelten C, Levy J, Cogniau H, Marbehant P, Verhoef J, Kersters K, Butzler J-P, Vandamme P: Characterization and description of“Campylobacter upsaliensis” isolated from human feces. Journal of Clinical Microbiology 1990, 28: 1039–1046.
Sandstedt K, Ursing J, Walder M: ThermotolerantCampylobacter with no or weak catalase activity isolated from dogs. Current Microbiology 1983, 8: 209–213.
Goossens H, Vlaes L, DeBoeck M, Pot B, Kersters K, Levy J, DeMol P, Butzler JP, Vandamme P: Is“Campylobacter upsaliensis” an unrecognized cause of human diarrhoea? Lancet 1990, 335: 584–586.
Lastovica AJ, Ambrosio RE: Plasmid profiles of clinical isolates ofCampylobacter with no or weak catalase activity. South African Medical Journal 1986, 70: 337–338.
Megraud F, Bonnet F: Unusual campylobacters in human faeces. Journal of Infection 1986, 12: 275–276.
Steele TW, Sangster N, Lanser JA: DNA relatedness and biochemical features ofCampylobacter spp. isolated in central and south Australia. Journal of Clinical Microbiology 1985, 22: 71–74.
Taylor DE, Hiratsuka K, Mueller L: Isolation and characterization of catalase-negative and catalase-weak strains ofCampylobacter species, including“Campylobacter upsaliensis”, from humans with gastroenteritis. Journal of Clinical Microbiology 1989, 27: 2042–2045.
Walmsley SL, Karmali MA: Direct isolation of atypical thermophilicCampylobacter species from human feces on selective agar medium. Journal of Clinical Microbiology 1989, 27: 668–670.
Lastovica AJ, Le Roux E, Penner JL:“Campylobacter upsaliensis” isolated from blood cultures of pediatric patients. Journal of Clinical Microbiology 1989, 27: 657–659.
Patton CM, Shaffer N, Edmonds P, Barrett TJ, Lambert MA, Baker C, Perlman DM, Brenner DJ: Human disease associated with“Campylobacter upsaliensis” (catalase-negative or weakly positiveCampylobacter species) in the United States. Journal of Clinical Microbiology 1989, 27: 66–73.
Karmali MA, Simor AE, Roscoe M, Fleming PC, Smith SS, Lane J: Evaluation of a blood-free, charcoal-based selective medium for the isolation ofCampylobacter organisms from feces. Journal of Clinical Microbiology 1986, 23: 456–469.
Fox JG, Maxwell KO, Taylor NS, Runsick CD, Edmonds P, Brenner DJ:“Campylobacter upsaliensis” isolated from cats as identified by DNA relatedness and biochemical features. Journal of Clinical Microbiology 1989, 27: 2376–2378.
Karmali MA, De Grandis S, Fleming PC: Antimicrobial susceptibility ofCampylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrobial Agents and Chemotherapy 1981, 19: 593–597.
Ng LK, Stiles ME, Taylor DE: Inhibition ofCampylobacter coli andCampylobacter jejuni by antibiotics used in selective growth media. Journal of Clinical Microbiology 1985, 22: 510–514.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Preston, M.A., Simor, A.E., Walmsley, S.L. et al. In vitro susceptibility of“Campylobacter upsaliensis” to twenty-four antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 9, 822–824 (1990). https://doi.org/10.1007/BF01967382
Issue Date:
DOI: https://doi.org/10.1007/BF01967382